WO2000024338A1 - Balloon expandable covered stents - Google Patents
Balloon expandable covered stents Download PDFInfo
- Publication number
- WO2000024338A1 WO2000024338A1 PCT/IL1999/000451 IL9900451W WO0024338A1 WO 2000024338 A1 WO2000024338 A1 WO 2000024338A1 IL 9900451 W IL9900451 W IL 9900451W WO 0024338 A1 WO0024338 A1 WO 0024338A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- covering
- diameter
- free
- tube
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/082—Inorganic materials
- A61L31/088—Other specific inorganic materials not covered by A61L31/084 or A61L31/086
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/909—Method or apparatus for assembling prosthetic
Definitions
- the present invention relates to implantable medical devices and to covered implantable stents comprising an elastic or superelastic material.
- Stents are support structures that are implanted in tubular organs, blood vessels or other tubular body lumens to help keep such conduits open. Stents are often used following balloon angioplasty to prevent restenosis and may, more generally, be used in repairing any of a number of other tubular body lumens, such as those in the vascular, biliary, genitourinary, gastrointestinal, respiratory and other systems .
- stents must be chemically and biologically inert to living tissue. Stents must further be able to stay in position and continue to support the tubular body lumens into which they are implanted over extended periods of time. Moreover, stents must have the ability to expand from a contracted state, which facilitates insertion into a body lumen, to an expanded diameter that is useful in supporting at least a portion of the body lumen. This expansion is accomplished either mechanically, such as by the action of a balloon- ended catheter, or by self-expansion such as by shape- memory effects or by the use of a constrained elastic stent .
- nitinol is highly elastic such that it is able to undergo extensive deformation and yet return to its original shape.
- Elastic stents are typically deployed in a body lumen by reducing the diameter of the stent by mechanical means, restraining the stent in the reduced diameter during insertion into the body, and releasing the stent from the restraint at a target location. Once released, the stent "self-expands" to its predetermined, useful diameter by virtue of its elastic properties.
- elastic stents are able to "rebound" to their useful diameters after being deformed by external forces .
- the resilient nature of such stents not only make them ideal for self-expansion upon delivery to a target location, but it also makes them desirable for use in body lumens that are often subjected to external forces and corresponding temporary reductions in diameter or other deformations.
- elastic stents are useful for placement in the carotid artery, which is frequently deformed by external forces because the vessel is in close proximity to the body surface.
- the present invention provides stents for deploying within tubular organs, blood vessels, or other tubular body lumens.
- Such stents comprise a stent body comprising an elastic material, the stent body being characterized by a free cylindrical shape having a free diameter.
- the stent body is at least partially covered with a covering that substantially prevents the stent body from expanding towards its free diameter when the stent body is placed into a diameter smaller than the free diameter.
- the covering does not force the stent body to a diameter
- the covering is a metal coating on the stent body.
- the covering is a tube around the stent body.
- the covering includes multiple rings around the stent body.
- the present invention also provides methods for deploying the stents of the present invention within tubular organs, blood vessels, or other tubular body lumens .
- the method includes the steps of providing a stent comprising a stent body comprising an elastic material, the stent body being characterized by a free cylindrical shape having a free diameter; deforming the stent to a diameter smaller than the free diameter; covering the stent with a covering that substantially prevents the stent body from expanding towards the free diameter when the stent body is placed into a diameter smaller than the free diameter; inserting the stent into the body while in the reduced diameter; and mechanically expanding the stent.
- the step of covering the stent comprises the step of coating the stent body.
- the step of covering the stent comprises the step of placing a tube over the stent.
- the step of covering the stent comprises the step of placing multiple rings over the stent.
- One advantage of the present invention is that it provides stents that are isothermally deployed in the body. /Another advantage of the present invention is that it provides stents that resist loads exerted by a surrounding tubular organ.
- Another advantage of the present invention is that it provides expanded stents that are reboundable and resilient along their longitudinal and radial axes, and thus resist deformation when exposed to longitudinal and radial forces.
- Yet another advantage of the present invention is that it provides stents that are expanded to controlled, desired dimensions by balloon catheters, and each stent can be expanded to any diameter within a wide range of diameters .
- Figs. 1A and IB show planar and cross-sectional views, respectively, of an embodiment of the present invention in which a stent is covered with a metal coating.
- Fig. 2 shows an embodiment of the present invention in which a stent is covered with a tube.
- Fig. 3 shows an embodiment of the present invention in which multiple rings are situated around a stent .
- Figs. 4A to 4C show a cross-sectional view of a method for deploying a stent into a body lumen, in accordance with the present invention.
- the present invention exploits the advantages of conventional elastic stents while minimizing the potential limitations and drawbacks of such stents.
- the stents of the present invention are not limited to predetermined "learned" diameters and do not require post- placement dilation procedures separate from the deployment stage.
- the stents of the present invention are each expandable to a range of useful diameters .
- the stents of the present invention are resilient such that they rebound to their expanded diameters after being subjected to external forces that result in temporary reductions in diameter or other deformations .
- the stents of the present invention comprise a stent body comprising an elastic material, and a covering on the stent body.
- the covering substantially prevents the stent body from expanding towards its free diameter when the stent body is placed into some smaller diameter.
- a stent of the present invention is deployed within a body lumen by deforming the stent to a diameter smaller than its free diameter, covering the stent with a covering that substantially prevents the stent from expanding towards its free diameter by virtue of its elastic properties, inserting the stent into the body lumen, and mechanically expanding the stent such as by balloon inflation to a desired, useful diameter at a target location within the body lumen.
- a stent 100 has a stent body 110 having a free cylindrical shape of free diameter, d.
- the cylindrical shape and diameter, d, of the stent body 110 are said to be "free" when the stent body 110 is not acted upon by external forces.
- the stent 100 is in the form of a patterned tube, other suitable stent configurations (for example, wire coil, braids, hexagons, nets, spiral ribbons, zig-zags, articulated stents, and the like) are also within the scope of the present invention.
- the stent body 110 comprises an elastic material that is able to undergo appreciable recoverable (elastic) deformation upon the application of external forces without incurring extensive permanent (plastic) deformation.
- the elastic material is preferably characterized by recoverable strains greater than about 1%, more preferably greater than about 5%.
- the elastic material is, for example, a metallic or polymeric material.
- the elastic material includes so-called "superelastic" materials such as certain nitinol alloys, which are typically characterized by recoverable strains greater than about 8%.
- Nitinol is a preferred material for the stent body 110. Because the stent body 110 comprises an elastic material, it tends to spring back to its free configuration and free diameter after being deformed or compressed by external forces.
- the stent 100 includes a covering on the stent body 110 that substantially prevents the stent body 110 from expanding towards its free diameter when it is placed into a diameter smaller than its free diameter. Moreover, ' the covering holds the stent body 110 to the diameter to which it is expanded once positioned in a target location in the body. Therefore, in accordance with the present invention, it is not required that the useful diameter to which the stent may be expanded be substantially equal to the free diameter of the stent body 110.
- the covering on the stent body 110 is not required that the useful diameter to which the stent may be expanded be substantially equal to the free diameter of the stent body 110.
- the 110 is a coating 102 that preferably comprises a plastically deformable metal.
- the coating 102 optionally comprises an x-ray absorbing material, thus rendering the stent 100 radiopaque .
- Preferred materials for the coating 102 include gold, platinum, palladium and tantalum.
- the coating 102 is applied to the stent body 110 by any suitable method such as, for example, dipping, spraying, vapor deposition, chemical or electrochemical plating, sputtering and the like.
- a preferred method for applying the coating 102 to the stent body 110 is by electroplating.
- the coating 102 is applied to a thickness, t(102), on the underlying stent body 110, the struts of which are characterized by a thickness, t(101), as shown in the cross-sectional view illustrated in Fig. IB.
- the stent body 110 is either partially or completely covered with the coating 102.
- the thickness of the coating 102, t(102) is sufficient to provide the strength necessary to hold the stent body 110 at the reduced diameter, thus negating any tendency of the stent body 110 to expand to its free diameter, d, by virtue of its elastic properties.
- the coating 102 comprises a soft, pliable metal such as gold
- the stent body 110 comprises nitinol
- the thickness of the coating 102 preferably approximates the cross-sectional thickness of the stent body struts.
- the coating 102 comprises a stronger metal, its thickness need not be as thick as the underlying stent body struts .
- the coating 102 imparts desired properties to the stent 100.
- its compression resistance is a combination of the strength of the stent body 110 and the strength of the coating material, which is plastically deformed during expansion of the stent 100.
- the radial resistance of the stent 100 against stent collapse and recoil after deployment is thus greatly enhanced by the coating 102.
- the coated stents of the present invention have the further advantage of being resilient in the longitudinal and radial directions, thereby resisting permanent deformation by longitudinal and radial forces.
- the coating 102 to the stent 100 substantially prevents the stent body 110 from expanding towards its free diameter, it is not necessary to restrain the stent from expanding such as by sheath or other restraining means during insertion into the body.
- Fig . 2 shows another embodiment of the present invention in which the stent 100 comprises a stent body 110 covered with a tube 202 rather than the coating 102 of the embodiment shown in Fig. IB.
- the tube 202 comprises any suitable biocompatible material having sufficient strength to substantially prevent the stent body 110 from expanding towards its free diameter after the stent body 110 is placed into a diameter smaller than the free diameter.
- a preferred material for the tube 202 is implant-grade medical polyurethane .
- the length of the tube 202 is substantially the length of the stent 100.
- the thickness of the tube 202 is sufficient to provide the strength necessary to hold the stent body 110 at the reduced diameter, thus negating any tendency of the stent body 110 to expand to its free diameter, d, by virtue of its elastic properties.
- the tube 202 is approximately 100 to 200 microns in thickness.
- the tube 202 has potentially multiple functions.
- the tube 202 prevents the stent body 110 from expanding to its free diameter after the stent body 110 is placed into a diameter smaller than the free diameter. Furthermore, because the length of the tube 202 is substantially the length of the stent body 110, it serves to limit embolization and growth through the openings between the struts of the stent 100. As another example, the tube 202 is optionally used for holding drug agents during delivery to a target location, whereupon the drug agents are released from the tube 202. For example, the tube 202 has drug " agents embedded therein, which are subsequently released from the tube 202 at the target location to prevent or limit neo-intimal proliferation.
- FIG. 3 Another embodiment of the present invention is shown in Fig. 3. This embodiment is similar to that shown in Fig. 2 with the exception that the embodiment shown in Fig. 3 includes multiple tubes or rings 302, each having a length less than that of the stent body 110. This embodiment is preferred over the embodiment shown in Fig. 2 in applications where the use of minimally covered stents are desired.
- the present invention provides methods for deploying the stent 100 within a body lumen.
- the method includes the steps of providing a stent comprising a stent body comprising an elastic material, the stent body being characterized by a free cylindrical shape having a free diameter; deforming the stent body to a diameter smaller than its free diameter; covering the stent with ' a covering that substantially prevents the stent body from expanding towards said free diameter by virtue of its elastic properties; inserting the stent into the body; and mechanically expanding the stent at a target location within the body lumen to a desired, useful diameter.
- the covering substantially prevents the stent from expanding during insertion into the body and placement to a target location within a body lumen.
- a stent of the present invention is expandable to a wide range of diameters, and it is not required that the useful diameter to which the stent is expanded be substantially equal to the free diameter of the stent body.
- a method of deploying a stent is described with reference to Figs. 4A to 4C, which illustrate (in cross- section) the deployment of a stent in an angioplasty procedure as a non-limiting example of the present invention.
- a stent having a stent body 110 and coating 102 on the stent body struts is mounted on a catheter 401 having an expandable portion 402.
- the diameter of the stent when mounted on the catheter 401 is less than its free diameter.
- the stent body 110 comprises an elastic material
- the coating 102 is of sufficient strength to substantially prevent the stent body 110 from expanding towards its free diameter by virtue of its elastic properties.
- the catheter 401 is positioned within a body lumen 501 having a blockage caused by plague buildup 502, for example.
- the expandable portion 402 of the catheter 401 is expanded by known techniques so to expand the stent to a desired, useful dimension as shown in Fig. 4B.
- the metal coating 102 on the stent body 110 undergoes plastic deformation.
- the expandable portion 402 of the catheter 401 is thereafter deflated to facilitate removal of the catheter 401 from the body lumen 501, as shown in Fig. 4C.
- the stent remains in place in an expanded configuration as shown in Fig. 4C.
- a patterned tube stent is made from nitinol having an approximate composition of 51 atomic percent nickel, balance titanium.
- the thickness of the stent struts is approximately 100 microns.
- the stent has a free diameter of about 5 millimeters.
- the stent is electroplated with gold using conventional techniques to a thickness of approximately 100 microns.
- the stent is thereafter deformed at room temperature, while the nitinol is in an austenitic phase, to a diameter of approximately 1 millimeter.
- the gold coating holds the stent to a diameter of approximately 1 millimeter.
- the coated stent is crimped onto the expandable portion of a conventional balloon catheter.
- the balloon catheter is delivered to a target location within a body lumen having a diameter of approximately 5 millimeters .
- the balloon catheter is expanded to a diameter of between about 3 to about 5 millimeters.
- the stent is likewise expanded to a diameter of between about 3 to about 5 millimeters and the gold layer is plastically deformed but remains as an intact coating.
- the balloon catheter is thereafter deflated and removed from the body, leaving the expanded stent in place at the target location.
- the deployed stent has high strength due to its austenitic phase and the additional strength imparted from the plastically deformed gold coating layer.
- the deployed stent has excellent resistance to recoil and collapse while maintaining resiliency in the longitudinal direction (i.e., reboundability) .
- a patterned tube stent is made from nitinol having an approximate composition of 51 atomic percent nickel, balance titanium.
- the thickness of the stent struts is approximately 100 microns.
- the stent has a free diameter of about 5 millimeters.
- the stent is cooled in ice water to place the nitinol in a martensitic phase and deformed while cold to a diameter of approximately 1 millimeter.
- a polyurethane tube having a diameter of approximately 1.5 millimeters and a thickness of approximately 150 microns, is placed over the stent. Both the stent and the polyurethane tube have a length of about 1.5 centimeters . The polyurethane tube holds the stent to a diameter of approximately 1 millimeter.
- the covered stent is crimped onto the expandable portion of a conventional balloon catheter.
- the balloon catheter is delivered to a target location within a body lumen having a diameter of approximately 5 millimeters.
- the balloon catheter When the stent is positioned to the target location, the balloon catheter is expanded to a diameter of between about 3 to about 5 millimeters. During such expansion, both the stent and the polyurethane tube are likewise expanded to a diameter of between about 3 to about
- the balloon catheter is thereafter deflated and removed from the body, leaving the expanded stent and the polyurethane tube in place at the target location.
- the deployed stent has high strength due to its austenitic phase and the additional strength imparted from the plastically deformed gold coating layer.
- the deployed stent has excellent resistance to recoil and collapse while maintaining resiliency in the longitudinal direction (i.e., reboundability).
- the present invention provides stents of improved strength that are isothermally deployed in the body without the need for restraining devices .
- the stents When deployed in accordance with the present invention, the stents provide sufficient strength to resist recoil and collapse while maintaining resiliency in the longitudinal direction.
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU53841/99A AU5384199A (en) | 1998-10-26 | 1999-08-22 | Balloon expandable covered stents |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/178,571 US6475234B1 (en) | 1998-10-26 | 1998-10-26 | Balloon expandable covered stents |
US09/178,571 | 1998-10-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000024338A1 true WO2000024338A1 (en) | 2000-05-04 |
Family
ID=22653076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL1999/000451 WO2000024338A1 (en) | 1998-10-26 | 1999-08-22 | Balloon expandable covered stents |
Country Status (25)
Country | Link |
---|---|
US (2) | US6475234B1 (en) |
EP (1) | EP0997116B1 (en) |
JP (1) | JP2000135290A (en) |
KR (1) | KR20000028636A (en) |
CN (1) | CN1252258A (en) |
AR (1) | AR021817A1 (en) |
AT (1) | ATE242618T1 (en) |
AU (2) | AU769653B2 (en) |
BR (1) | BR9904182A (en) |
CA (1) | CA2281263C (en) |
DE (2) | DE69908736T2 (en) |
DK (1) | DK0997116T3 (en) |
EE (1) | EE9900519A (en) |
ES (1) | ES2200453T3 (en) |
GB (1) | GB2343119B (en) |
IL (1) | IL131522A (en) |
NO (1) | NO316423B1 (en) |
NZ (1) | NZ337616A (en) |
PL (1) | PL336064A1 (en) |
PT (1) | PT997116E (en) |
RU (1) | RU2214840C2 (en) |
SG (1) | SG73666A1 (en) |
SK (1) | SK147099A3 (en) |
UA (1) | UA62959C2 (en) |
WO (1) | WO2000024338A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6315791B1 (en) | 1996-12-03 | 2001-11-13 | Atrium Medical Corporation | Self-expanding prothesis |
WO2014188437A2 (en) | 2013-05-23 | 2014-11-27 | S.T.S. Medical Ltd. | Shape change structure |
US9028543B2 (en) | 2002-03-25 | 2015-05-12 | Kieran Murphy, Llc | Device viewable under an imaging beam |
EP2399550B1 (en) | 2001-10-11 | 2016-04-06 | Edwards Lifesciences PVT, Inc. | System for replacing a deficient native heart valve |
US9375203B2 (en) | 2002-03-25 | 2016-06-28 | Kieran Murphy Llc | Biopsy needle |
US9427254B2 (en) | 2002-03-25 | 2016-08-30 | Kieran Murphy Llc | Apparatus for use in a surgical procedure |
US10912663B2 (en) | 2014-11-26 | 2021-02-09 | S.T.S. Medical Ltd. | Shape change structure for treatment of nasal conditions including sinusitis |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6620192B1 (en) * | 1999-03-16 | 2003-09-16 | Advanced Cardiovascular Systems, Inc. | Multilayer stent |
US6572646B1 (en) * | 2000-06-02 | 2003-06-03 | Advanced Cardiovascular Systems, Inc. | Curved nitinol stent for extremely tortuous anatomy |
JP3322867B1 (en) * | 2001-02-20 | 2002-09-09 | エスエムエー メディカル インコーポレーテッド | Insertion member for insertion into tubular organ of living body and method of manufacturing the same |
DK174876B1 (en) * | 2001-02-26 | 2004-01-12 | Danfoss As | Implant and implant surface modification process |
US7842083B2 (en) | 2001-08-20 | 2010-11-30 | Innovational Holdings, Llc. | Expandable medical device with improved spatial distribution |
EP1441669B1 (en) * | 2001-11-09 | 2009-03-25 | AngioScore, Inc. | Baloon catheter with non-deployable stent |
US6807440B2 (en) * | 2001-11-09 | 2004-10-19 | Scimed Life Systems, Inc. | Ceramic reinforcement members for MRI devices |
US20040111108A1 (en) | 2001-11-09 | 2004-06-10 | Farnan Robert C. | Balloon catheter with non-deployable stent |
US6989024B2 (en) * | 2002-02-28 | 2006-01-24 | Counter Clockwise, Inc. | Guidewire loaded stent for delivery through a catheter |
US20030204248A1 (en) * | 2002-03-25 | 2003-10-30 | Murphy Kieran P. | Device viewable under an imaging beam |
DE10226734A1 (en) * | 2002-05-10 | 2003-11-20 | Lothar Sellin | Stent consists of a material with shape memory activatable by temperature, with the stent diameter varying within given ranges at temperatures below and above a specified level |
US20040093056A1 (en) | 2002-10-26 | 2004-05-13 | Johnson Lianw M. | Medical appliance delivery apparatus and method of use |
US7637942B2 (en) | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
US7875068B2 (en) | 2002-11-05 | 2011-01-25 | Merit Medical Systems, Inc. | Removable biliary stent |
US7959671B2 (en) | 2002-11-05 | 2011-06-14 | Merit Medical Systems, Inc. | Differential covering and coating methods |
US8080026B2 (en) | 2003-01-21 | 2011-12-20 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
US7686824B2 (en) | 2003-01-21 | 2010-03-30 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
US7318836B2 (en) | 2003-03-11 | 2008-01-15 | Boston Scientific Scimed, Inc. | Covered stent |
US20050049672A1 (en) * | 2003-03-24 | 2005-03-03 | Murphy Kieran P. | Stent delivery system and method using a balloon for a self-expandable stent |
US7637934B2 (en) | 2003-03-31 | 2009-12-29 | Merit Medical Systems, Inc. | Medical appliance optical delivery and deployment apparatus and method |
US20050049666A1 (en) * | 2003-08-26 | 2005-03-03 | Chien Thomas Yung-Hui | Stent delivery system |
JP3977790B2 (en) * | 2003-09-01 | 2007-09-19 | 古河サーキットフォイル株式会社 | Manufacturing method of ultra-thin copper foil with carrier, ultra-thin copper foil manufactured by the manufacturing method, printed wiring board using the ultra-thin copper foil, multilayer printed wiring board, chip-on-film wiring board |
US20050165472A1 (en) * | 2004-01-22 | 2005-07-28 | Glocker David A. | Radiopaque coating for biomedical devices |
WO2006004645A2 (en) * | 2004-06-28 | 2006-01-12 | Isoflux, Inc. | Porous coatings for biomedical implants |
US7481835B1 (en) * | 2004-10-29 | 2009-01-27 | Advanced Cardiovascular Systems, Inc. | Encapsulated covered stent |
DE202005001416U1 (en) | 2005-01-28 | 2005-03-31 | Urovision Ges Fuer Medizinisch | stent |
DE102005013547B4 (en) | 2005-03-23 | 2009-02-05 | Admedes Schuessler Gmbh | Aneurysm stent and process for its preparation |
KR100678435B1 (en) | 2005-04-13 | 2007-02-02 | 주식회사 에스앤지바이오텍 | Tube type stent of covering wall of blood vessel |
DE102005019612B4 (en) | 2005-04-27 | 2010-11-25 | Admedes Schuessler Gmbh | Mechanical locking of an X-ray marker in the eyelet of a stent or in another body implant |
US20060248698A1 (en) * | 2005-05-05 | 2006-11-09 | Hanson Brian J | Tubular stent and methods of making the same |
US10076641B2 (en) | 2005-05-11 | 2018-09-18 | The Spectranetics Corporation | Methods and systems for delivering substances into luminal walls |
DE102005024626B3 (en) | 2005-05-30 | 2006-09-14 | Siemens Ag | Catheter for insertion and creation of a stent within a body conduit has a filling space that is filled with plastic at the point at which the stent is to be created and then the plastic hardened prior to removal of the catheter |
DE102005039136B4 (en) | 2005-08-18 | 2011-07-28 | Admedes Schuessler GmbH, 75179 | Improving the radiopacity and corrosion resistance of NiTi stents using sandwiched rivets |
US20070061001A1 (en) * | 2005-09-13 | 2007-03-15 | Advanced Cardiovascular Systems, Inc. | Packaging sheath for drug coated stent |
DE102005056529A1 (en) * | 2005-11-28 | 2007-05-31 | Mnemoscience Gmbh | Compressible tubular material support or stent for insertion into vessels to be supported has tube folded one or more times in its longitudinal axis in temporary form of shape memory material |
DE102006040301A1 (en) * | 2005-12-06 | 2008-03-06 | Düring, Klaus, Dr. | Device for splinting a cavity, organ path and / or vessel |
DE102006007231B4 (en) * | 2006-02-15 | 2009-04-09 | Acandis Gmbh & Co. Kg | Method of wrapping a stent |
KR20060030075A (en) * | 2006-02-15 | 2006-04-07 | 전말수 | Bio artificial tear tube |
US8828091B2 (en) * | 2006-03-23 | 2014-09-09 | Boston Scientific Scimed, Inc. | Movable stent reinforcement |
GB0621048D0 (en) * | 2006-10-23 | 2006-11-29 | Anson Medical Ltd | Helical stent graft |
WO2008097511A2 (en) * | 2007-02-07 | 2008-08-14 | Cook Incorporated | Medical device coatings for releasing a therapeutic agent at multiple rates |
US9144508B2 (en) | 2007-07-19 | 2015-09-29 | Back Bay Medical Inc. | Radially expandable stent |
DE102007036685A1 (en) * | 2007-08-03 | 2009-02-05 | Innora Gmbh | Improved drug-coated medical devices their manufacture and use |
US20090105687A1 (en) * | 2007-10-05 | 2009-04-23 | Angioscore, Inc. | Scoring catheter with drug delivery membrane |
US8142490B2 (en) | 2007-10-24 | 2012-03-27 | Cordis Corporation | Stent segments axially connected by thin film |
KR100956064B1 (en) * | 2008-06-27 | 2010-05-07 | 주식회사 엠아이텍 | Stent |
US8828040B2 (en) * | 2009-07-07 | 2014-09-09 | Thomas G. Goff | Device and methods for delivery and transfer of temporary radiopaque element |
EP2477558B1 (en) | 2009-09-14 | 2016-08-10 | CircuLite, Inc. | Endovascular anastomotic connector device and delivery system |
US8333727B2 (en) * | 2009-10-08 | 2012-12-18 | Circulite, Inc. | Two piece endovascular anastomotic connector |
EP2380604A1 (en) | 2010-04-19 | 2011-10-26 | InnoRa Gmbh | Improved coating formulations for scoring or cutting balloon catheters |
WO2012025245A1 (en) | 2010-08-26 | 2012-03-01 | Acandis Gmbh & Co. Kg | Electrode for medical applications, system having such an electrode, and method for producing such an electrode |
US9220899B2 (en) * | 2010-08-26 | 2015-12-29 | Acandis Gmbh & Co. Kg | Electrode for medical applications, system having an electrode, and method for producing an electrode |
US8632559B2 (en) | 2010-09-21 | 2014-01-21 | Angioscore, Inc. | Method and system for treating valve stenosis |
DE102011115902B4 (en) * | 2010-12-22 | 2021-07-01 | Bentley Innomed Gmbh | Stent-graft and its use |
US9782282B2 (en) | 2011-11-14 | 2017-10-10 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
US9877858B2 (en) | 2011-11-14 | 2018-01-30 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
US9375308B2 (en) | 2012-03-13 | 2016-06-28 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
WO2013177109A1 (en) | 2012-05-21 | 2013-11-28 | Medplate Lifesciences Corporation | Collapsible, shape memory alloy structures and folding fixtures for collapsing same |
US10117668B2 (en) | 2013-10-08 | 2018-11-06 | The Spectranetics Corporation | Balloon catheter with non-deployable stent having improved stability |
EP3071156B1 (en) * | 2013-11-19 | 2021-05-05 | W. L. Gore & Associates, Inc. | Steerable catheter for use in endoluminal deployment of expandable devices |
RU2566082C1 (en) * | 2014-04-11 | 2015-10-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ГБОУ ВПО РНИМУ им. Н.И. Пирогова Минздрава России) | Pancreatic stent |
DE102015106052B4 (en) * | 2015-04-21 | 2018-03-01 | Nikola Obradovic | Stent graft |
RU2615861C2 (en) * | 2015-06-16 | 2017-04-11 | Валерий Вильгельмович Петрашкевич | Implant device for human and animal blood vessels |
CN107822686B (en) * | 2017-11-01 | 2020-06-05 | 西安交通大学医学院第一附属医院 | Outer sleeve type blood flow blocking plug |
RU185120U1 (en) * | 2018-07-11 | 2018-11-22 | Государственное бюджетное учреждение здравоохранения города Москвы Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского Департамента здравоохранения г. Москвы | STENT FOR ENDOSCOPIC TREATMENT OF FISCULAR FUMES OF THE NON-MALIGNANT GENESIS |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5522882A (en) * | 1994-10-21 | 1996-06-04 | Impra, Inc. | Method and apparatus for balloon expandable stent-graft delivery |
US5725572A (en) * | 1994-04-25 | 1998-03-10 | Advanced Cardiovascular Systems, Inc. | Radiopaque stent |
US5824045A (en) * | 1996-10-21 | 1998-10-20 | Inflow Dynamics Inc. | Vascular and endoluminal stents |
US5922020A (en) * | 1996-08-02 | 1999-07-13 | Localmed, Inc. | Tubular prosthesis having improved expansion and imaging characteristics |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3620212A (en) | 1970-06-15 | 1971-11-16 | Robert D Fannon Jr | Intrauterine contraceptive device |
US4425908A (en) | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4494531A (en) | 1982-12-06 | 1985-01-22 | Cook, Incorporated | Expandable blood clot filter |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4795458A (en) * | 1987-07-02 | 1989-01-03 | Regan Barrie F | Stent for use following balloon angioplasty |
US5207706A (en) | 1988-10-05 | 1993-05-04 | Menaker M D Gerald | Method and means for gold-coating implantable intravascular devices |
US5464438A (en) * | 1988-10-05 | 1995-11-07 | Menaker; Gerald J. | Gold coating means for limiting thromboses in implantable grafts |
JP2740867B2 (en) | 1988-10-07 | 1998-04-15 | バリー・エフ・リーガン | Stent and its manufacturing method |
US5628790A (en) | 1989-07-25 | 1997-05-13 | Smith & Nephew, Inc. | Zirconium oxide zirconium nitride coated valvular annuloplasty rings |
IL94138A (en) | 1990-04-19 | 1997-03-18 | Instent Inc | Device for the treatment of constricted fluid conducting ducts |
US5258020A (en) | 1990-09-14 | 1993-11-02 | Michael Froix | Method of using expandable polymeric stent with memory |
JPH0717314Y2 (en) * | 1990-10-18 | 1995-04-26 | ソン ホーヨン | Self-expanding intravascular stent |
DE4104702C2 (en) | 1991-02-15 | 1996-01-18 | Malte Neuss | Implants for organ pathways in spiral form |
US5147370A (en) | 1991-06-12 | 1992-09-15 | Mcnamara Thomas O | Nitinol stent for hollow body conduits |
US5316023A (en) * | 1992-01-08 | 1994-05-31 | Expandable Grafts Partnership | Method for bilateral intra-aortic bypass |
US5282823A (en) * | 1992-03-19 | 1994-02-01 | Medtronic, Inc. | Intravascular radially expandable stent |
US5383927A (en) | 1992-05-07 | 1995-01-24 | Intervascular Inc. | Non-thromogenic vascular prosthesis |
ES2166370T3 (en) | 1993-01-19 | 2002-04-16 | Schneider Usa Inc | IMPLANTABLE FILAMENT IN COMPOSITE MATERIAL. |
NL9300500A (en) | 1993-03-22 | 1994-10-17 | Industrial Res Bv | Expandable hollow sleeve for locally supporting and / or strengthening a body vessel, as well as a method for manufacturing it. |
IL109169A (en) * | 1993-03-30 | 1999-06-20 | Instent Inc | Temporary stent system |
US5735892A (en) * | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
WO1995031945A1 (en) | 1994-05-19 | 1995-11-30 | Scimed Life Systems, Inc. | Improved tissue supporting devices |
IL115755A0 (en) | 1994-10-27 | 1996-01-19 | Medinol Ltd | X-ray visible stent |
AU3783195A (en) | 1994-11-15 | 1996-05-23 | Advanced Cardiovascular Systems Inc. | Intraluminal stent for attaching a graft |
JP3585970B2 (en) | 1994-11-24 | 2004-11-10 | テルモ株式会社 | In-vivo stent |
DE4446036C2 (en) * | 1994-12-23 | 1999-06-02 | Ruesch Willy Ag | Placeholder for placement in a body tube |
JP3640696B2 (en) | 1995-02-27 | 2005-04-20 | テルモ株式会社 | Luminal organ treatment device |
CA2171896C (en) | 1995-03-17 | 2007-05-15 | Scott C. Anderson | Multi-anchor stent |
US5628786A (en) | 1995-05-12 | 1997-05-13 | Impra, Inc. | Radially expandable vascular graft with resistance to longitudinal compression and method of making same |
AU716005B2 (en) * | 1995-06-07 | 2000-02-17 | Cook Medical Technologies Llc | Implantable medical device |
US5607442A (en) | 1995-11-13 | 1997-03-04 | Isostent, Inc. | Stent with improved radiopacity and appearance characteristics |
WO1997021403A1 (en) | 1995-12-14 | 1997-06-19 | Prograft Medical, Inc. | Kink-resistant stent graft |
WO1997037617A1 (en) * | 1996-04-08 | 1997-10-16 | Swaminathan Jayaraman | Multiple interconnected stents and method of coating stents |
US5713949A (en) | 1996-08-06 | 1998-02-03 | Jayaraman; Swaminathan | Microporous covered stents and method of coating |
US5741326A (en) | 1996-07-15 | 1998-04-21 | Cordis Corporation | Low profile thermally set wrapped cover for a percutaneously deployed stent |
US5670573A (en) | 1996-08-07 | 1997-09-23 | E. I. Du Pont De Nemours And Company | Coatings containing fluorinated esters |
US6174329B1 (en) * | 1996-08-22 | 2001-01-16 | Advanced Cardiovascular Systems, Inc. | Protective coating for a stent with intermediate radiopaque coating |
US5824046A (en) * | 1996-09-27 | 1998-10-20 | Scimed Life Systems, Inc. | Covered stent |
US6086610A (en) * | 1996-10-22 | 2000-07-11 | Nitinol Devices & Components | Composite self expanding stent device having a restraining element |
US6352561B1 (en) | 1996-12-23 | 2002-03-05 | W. L. Gore & Associates | Implant deployment apparatus |
US6241757B1 (en) * | 1997-02-04 | 2001-06-05 | Solco Surgical Instrument Co., Ltd. | Stent for expanding body's lumen |
WO1998038947A1 (en) | 1997-03-05 | 1998-09-11 | Scimed Life Systems, Inc. | Conformal laminate stent device |
US5779732A (en) | 1997-03-31 | 1998-07-14 | Medtronic, Inc. | Method and apparatus for implanting a film with an exandable stent |
US5855600A (en) * | 1997-08-01 | 1999-01-05 | Inflow Dynamics Inc. | Flexible implantable stent with composite design |
US5899935A (en) | 1997-08-04 | 1999-05-04 | Schneider (Usa) Inc. | Balloon expandable braided stent with restraint |
WO1999065419A1 (en) | 1998-06-19 | 1999-12-23 | Endologix, Inc. | Self expanding bifurcated endovascular prosthesis |
-
1998
- 1998-10-26 US US09/178,571 patent/US6475234B1/en not_active Expired - Lifetime
-
1999
- 1999-08-18 SG SG1999004123A patent/SG73666A1/en unknown
- 1999-08-19 AU AU44595/99A patent/AU769653B2/en not_active Expired
- 1999-08-22 AU AU53841/99A patent/AU5384199A/en not_active Abandoned
- 1999-08-22 IL IL13152299A patent/IL131522A/en not_active IP Right Cessation
- 1999-08-22 WO PCT/IL1999/000451 patent/WO2000024338A1/en active Application Filing
- 1999-08-27 CA CA002281263A patent/CA2281263C/en not_active Expired - Lifetime
- 1999-09-02 NZ NZ337616A patent/NZ337616A/en unknown
- 1999-09-02 KR KR1019990037047A patent/KR20000028636A/en active Search and Examination
- 1999-09-16 BR BR9904182-0A patent/BR9904182A/en not_active IP Right Cessation
- 1999-09-20 AR ARP990104726A patent/AR021817A1/en not_active Application Discontinuation
- 1999-10-18 PL PL99336064A patent/PL336064A1/en not_active Application Discontinuation
- 1999-10-21 UA UA99105770A patent/UA62959C2/en unknown
- 1999-10-22 JP JP30083599A patent/JP2000135290A/en active Pending
- 1999-10-22 GB GB9924906A patent/GB2343119B/en not_active Expired - Lifetime
- 1999-10-25 EE EEP199900519A patent/EE9900519A/en unknown
- 1999-10-25 DK DK99120836T patent/DK0997116T3/en active
- 1999-10-25 EP EP99120836A patent/EP0997116B1/en not_active Expired - Lifetime
- 1999-10-25 NO NO19995202A patent/NO316423B1/en not_active IP Right Cessation
- 1999-10-25 DE DE69908736T patent/DE69908736T2/en not_active Expired - Lifetime
- 1999-10-25 PT PT99120836T patent/PT997116E/en unknown
- 1999-10-25 ES ES99120836T patent/ES2200453T3/en not_active Expired - Lifetime
- 1999-10-25 DE DE19951279A patent/DE19951279A1/en not_active Ceased
- 1999-10-25 CN CN99123150A patent/CN1252258A/en active Pending
- 1999-10-25 AT AT99120836T patent/ATE242618T1/en not_active IP Right Cessation
- 1999-10-25 RU RU99122520/14A patent/RU2214840C2/en not_active IP Right Cessation
- 1999-10-26 SK SK1470-99A patent/SK147099A3/en unknown
-
2002
- 2002-09-03 US US10/234,701 patent/US6887265B2/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5725572A (en) * | 1994-04-25 | 1998-03-10 | Advanced Cardiovascular Systems, Inc. | Radiopaque stent |
US5522882A (en) * | 1994-10-21 | 1996-06-04 | Impra, Inc. | Method and apparatus for balloon expandable stent-graft delivery |
US5922020A (en) * | 1996-08-02 | 1999-07-13 | Localmed, Inc. | Tubular prosthesis having improved expansion and imaging characteristics |
US5824045A (en) * | 1996-10-21 | 1998-10-20 | Inflow Dynamics Inc. | Vascular and endoluminal stents |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6315791B1 (en) | 1996-12-03 | 2001-11-13 | Atrium Medical Corporation | Self-expanding prothesis |
EP2399550B1 (en) | 2001-10-11 | 2016-04-06 | Edwards Lifesciences PVT, Inc. | System for replacing a deficient native heart valve |
US9028543B2 (en) | 2002-03-25 | 2015-05-12 | Kieran Murphy, Llc | Device viewable under an imaging beam |
US9375203B2 (en) | 2002-03-25 | 2016-06-28 | Kieran Murphy Llc | Biopsy needle |
US9427254B2 (en) | 2002-03-25 | 2016-08-30 | Kieran Murphy Llc | Apparatus for use in a surgical procedure |
WO2014188437A2 (en) | 2013-05-23 | 2014-11-27 | S.T.S. Medical Ltd. | Shape change structure |
US10953141B2 (en) | 2013-05-23 | 2021-03-23 | S.T.S. Medical Ltd. | Shape change structure |
US10912663B2 (en) | 2014-11-26 | 2021-02-09 | S.T.S. Medical Ltd. | Shape change structure for treatment of nasal conditions including sinusitis |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6475234B1 (en) | Balloon expandable covered stents | |
EP1334701B1 (en) | Tubular medical prostheses | |
US6315791B1 (en) | Self-expanding prothesis | |
US7101392B2 (en) | Tubular medical endoprostheses | |
US7854760B2 (en) | Medical devices including metallic films | |
EP1725186B1 (en) | Medical devices including metallic films and methods for making same | |
MXPA99009850A (en) | Covered stents expanding through gl | |
CZ9903787A3 (en) | Stent and method of its location in body lumen | |
KR20030004283A (en) | Balloon expandable covered stents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |